Collaborateurs

16 people

A team with more than 20 years of experience in its fields of activity

Domaine d'activité

3 therapeutic areas

Hereditary metabolic diseases
Haematology - Oncology - Immunology
Gene and cell therapies

Pays

Present in more than 47 countries

Present on all 5 continents

We are a French pharmaceutical company with a strong and growing international presence. Since our creation in 2002, we have been committed to providing patients with health products when their medical needs are unmet. We focus particularly on rare diseases and work hand in hand with academic structures to offer patients access to the treatments the most adapted to their needs.

We believe that by working together we will be able to find, develop and market the treatments of tomorrow.

Plaquette d’information : Laboratoires CTRS - 2018

Brochure: CTRS – 2018

Latest article on LinkedIn

Actualités
28 February 2019

Today is #RareDiseaseDay 2019! Because of the lack of knowledge, millions of people across the world are struggling in search of an answer. Diagnostic wavering is particularly painful for patients and families. Getting the right diagnosis is the key to unlock access to medical and social care and to treatment. It’s the possibility for them to plan their future. Rare doesn’t mean loneliness. Show Your Rare, Show You Care! #RareDiseaseDay #ShowYourRare For more informations : https://www.eurordis.org/ - https://lnkd.in/dwNGAfV

Lire la suite...